KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
84 hedge funds and large institutions have $39.2M invested in Chinook Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 31 increasing their positions, 22 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
-4
Holders Change %
-4.55%
% of All Funds
1.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
31
Reduced
22
Closed
20
Calls
$31K
Puts
–
Net Calls
+$31K
Net Calls Change
+$33K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$2.24M |
| 2 |
Goldman Sachs
New York
|
+$740K |
| 3 |
JPMorgan Chase & Co
New York
|
+$364K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$331K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$320K |
Top Sellers
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$2.65M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.31M |
| 3 |
BlackRock
New York
|
-$1.1M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$1.07M |
| 5 |
HMC
Harvard Management Company
Boston,
Massachusetts
|
-$679K |
